Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of vorinostat and bortezomib in adults with progressive or recurrent glioblastoma multiforme; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bortezomib (bortezomib)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-10